TITLE

Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis

AUTHOR(S)
Hole, O.; Schouten, L. J.; Wolters, F. L.; Solberg, I. C.; Riis, I.; Mouzas, I. A.; Politi, P.; Odes, S.; Langholz, E.; Vatn, M.; Stockbrügger, R. W.; Mourn, B.
PUB. DATE
April 2007
SOURCE
Gut;Apr2007, Vol. 56 Issue 4, p497
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Population based studies have revealed varying mortality for patients with ulcerative colitis but most have described patients from limited geographical areas who were diagnosed before 1990. Aims: To assess overall mortality in a European cohort of patients with ulcerative colitis, 10 years after diagnosis, and to investigate national ulcerative colitis related mortality across Europe. Methods: Mortality 10 years after diagnosis was recorded in a prospective European-wide population based cohort of patients with ulcerative colitis diagnosed in 1991-1993 from nine centres in seven European countries. Expected mortality was calculated from the sex, age and country specific mortality in the WHO Mortality Database for 1995-1998. Standardised mortality ratios (SMR) and 95% confidence intervals (CI) were calculated. Results: At follow-up, 661 of 775 patients were alive with a median follow-up duration of 123 months (107-144). A total of 73 deaths (median follow-up time 61 months (1-133)) occurred compared with an expected 67. The overall mortality risk was no higher: SMR 1.09 (95% CI 0.86 to 1.37). Mortality by sex was SMR 0.92 (95% CI 0.65 to 1.26) for males and SMR 1.39 (95% CI 0.97 to 1.93) for females. There was a slightly higher risk in older age groups. For disease specific mortality, a higher SMR was found only for pulmonary disease. Mortality by European region was SMR 1.19 (95% CI 0.91 to 1.53) for the north and SMR 0.82 (95% CI 0.45-1.37) for the south. Conclusions: Higher mortality was not found in patients with ulcerative colitis 10 years after disease onset. However, a significant rise in SMR for pulmonary disease, and a trend towards an age related rise in SMR, was observed.
ACCESSION #
24767577

 

Related Articles

  • A new model for the discrimination between ulcerative colitis and Crohn's disease. Zhe Shen; Wei-Ping Ma; Xiao-Na Shao; Chao-Hui Yu; Juan Du; Zun Xiang; Gan-Hua Guo; Hong Zhang; You-Ming Li; Min Yue // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 1, p854 

    Distinguishing ulcerative colitis (UC) from Crohn's disease (CD) is sometimes difficult in a clinical setting. The purpose of this study was to identify a series of independent serum markers capable of distinguishing between UC and CD. 140 UC and 174 CD patients hospitalized at The First...

  • Isotretinoin Use and the Risk of Inflammatory Bowel Disease: A Case–Control Study. Crockett, Seth D.; Porter, Carol Q.; Martin, Christopher F.; Sandler, Robert S.; Kappelman, Michael D. // American Journal of Gastroenterology;Sep2010, Vol. 105 Issue 9, p1986 

    OBJECTIVES:Isotretinoin is commonly prescribed for the treatment of severe acne. Although cases of inflammatory bowel disease (IBD) have been reported in isotretinoin users, a causal association remains unproven.METHODS:We performed a case–control study using a large insurance claims...

  • Mortality Rates of Medical Therapy Vs Elective Colectomy for Treatment of Ulcerative Colitis. Alleman, Samantha // Gastroenterology & Hepatology;Aug2015, Vol. 11 Issue 8, p540 

    The article reports on research published in the July 14, 2015 issue of "Annals of Internal Medicine" which examined the mortality rates linked to elective colectomy versus medical therapy in advanced ulcerative colitis patients.

  • Ulcerative colitis. Ford, Alexander C.; Moayyedi, Paul; Hanauer, Steven B. // BMJ: British Medical Journal;2/9/2013, Vol. 346 Issue 7894, p29 

    The article discusses ulcerative colitis that affects the colorectum and is more common in young adulthood and developed nations. It describes the causes, associated conditions and treatment options. It also discusses treatment of refractory disease, colorectal cancer screening and osteoporosis...

  • Ulcerative colitis. Anonymous patient; Kelly, Sean // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/19/2012, Vol. 344 Issue 7857, p54 

    The article presents the author's insights on her journey to a diagnosis of ulcerative colitis, and how she overcame the diagnosis and sought further help in getting a diagnosis. The author states that her journey started when she suffered from constant diarrhoea while she was on a university...

  • Ulcerative Colitis and Electronic Cigarette: What's the Matter? Camus, Marine; Gallois, Glaire; Marteau, Philippe // American Journal of Gastroenterology;Apr2014, Vol. 109 Issue 4, p608 

    A letter to the editor is presented in which the authors described a case of a 49-year-old woman diagnosed with ulcerative colitis affecting her rectum and sigmoid colon, as she had been smoking 20 cigarettes per day for 20 years.

  • Differential Diagnosis of Ulcerative Lesions in Fish. Law, Mac // Environmental Health Perspectives Supplements;Oct2001 Supplement 5, Vol. 109, p681 

    Focuses on the differential diagnosis of ulcerative lesions in fish in North Carolina. Description of ulcerative myocis; Discussion on the pathogenesis of ulcerative syndromes; Ways in determining the causes of skin ulcers in fish.

  • Leczenie biologiczne infliksymabem ci&ecedil;żkiej postaci wrzodziej&acedil;cego zapalenia jelita grubego u dzieci. Szychta, Monika; Kierkuś, Jarosław; D&acedil;dalski, Maciej; Wegner, Agnieszka; Kmiotek, Jakub; Ryżko, Józef // Contemporary Pediatrics, Gastroenterology, Hepatology & Child Fe;2012, Vol. 14 Issue 2, p83 

    Introduction: Ulcerative colitis (UC) in children has a variable clinical course ranging from mild to severe phenotype, that needs infliximab therapy. UC diagnosed in early childhood worsens the prognosis. The second-line therapy con-sists either of cydosporine or infliximab. Treatment of UC...

  • Inflammatory Bowel Disease in Children, an Evolving Problem in Kuwait. Al-Qabandi, Wafa'a A.; Buhamrah, Eman K.; Hamadi, Khaled A.; Al-Osaimi, Suad A.; Al-Ruwayeh, Ahlam A.; Madda, JohnPatrick // Saudi Journal of Gastroenterology;Oct2011, Vol. 17 Issue 5, p323 

    Background/Aims: Inflammatory bowel disease (IBD) was previously thought a rare disease among children in Kuwait since most diarrhea cases were attributed to infections. In the past few years we observed an increase in the number of patients presenting with IBD. In this study we aimed to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics